Renaissance Technologies
CARL

Renaissance Technologies’s Carlsmed CARL Stock Holding History

Renaissance Technologies’s Portfolio CARL Stock Details CARL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.1K Sell
10,400
-13,900
-57% -$168K ﹤0.01% 3038
2025
Q4 		$300K Buy
+24,300
New +$323K ﹤0.01% 2762

Other funds holding CARL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KC
KCM Capital Shawnee, Kansas $622M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies's CARL Position: Q1 2026 in Review

Renaissance Technologies reduced its Carlsmed (CARL) stake by 57% in Q1 2026, selling an estimated $168K and leaving 10,400 shares worth $94.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3038.

Renaissance Technologies first reported a position in CARL in Q4 2025 and has held it in 2 quarters since. The position peaked at $300K in Q4 2025. 66 funds tracked by Wall St. Rank hold CARL as of Q1 2026.

  • Renaissance Technologies held 10,400 shares of Carlsmed worth $94.1K as of Q1 2026.
  • Renaissance Technologies sold 13,900 Carlsmed shares in Q1 2026, an estimated $168K.
  • Carlsmed made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #3038 holding.
  • Renaissance Technologies first reported a position in Carlsmed in Q4 2025 and has held it in 2 quarters since.
  • Renaissance Technologies's Carlsmed position peaked at $300K in Q4 2025.
  • 66 funds tracked by Wall St. Rank held Carlsmed as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.